Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag has been updated to v3.6.6, representing a small patch to the page's metadata. This change does not modify the core study content or how users interact with the page.SummaryDifference0.0%

- Check13 days agoChange DetectedA line noting NIH funding was added to the study record, indicating NIH grant/contract information for the trial. This addition provides funding context but does not alter the study design or eligibility.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows a new revision label, updated from v3.6.4 to v3.6.5, signaling a new version of the study details page was published. This indicates the page content or metadata was updated since the prior version.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.6.4 was added to reflect a small page revision, replacing the previous Revision: v3.6.3. This update serves as a metadata change and does not modify the underlying study information.SummaryDifference0.0%

- Check56 days agoChange DetectedNo textual changes are reported for this page based on the provided data.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision tag on the page changed from v3.6.2 to v3.6.3. This reflects an update to the page's documentation or metadata.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.